LataMed AI raises authorized shares to 3.5 billion and approves 5-for-1 split
LMED•Nevada filing expands share authorization
LataMed AI filed a Nevada Certificate of Change on July 2, 2026, increasing its authorized common share count to 3,500,000,000 from 700,000,000.
The filing also raised authorized preferred shares to 1,500,000,000 from 300,000,000.
5-for-1 forward split affects outstanding common stock
The same filing implemented a 5-for-1 forward split of LataMed AI's issued and outstanding common stock.
